EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Fennec Pharmaceuticals Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm – FENC

On this news, Fennecs stock price fell $3.51 per share, or 34%, to close at $6.66 per share on August 11, 2020, damaging investors.